SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-290707
Filing Date
2023-12-07
Accepted
2023-12-07 16:15:53
Documents
14
Period of Report
2023-12-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d634027d8k.htm   iXBRL 8-K 34192
2 EX-3.1 d634027dex31.htm EX-3.1 136441
3 EX-10.1 d634027dex101.htm EX-10.1 24508
  Complete submission text file 0001193125-23-290707.txt   369354

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA inab-20231206.xsd EX-101.SCH 2836
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE inab-20231206_lab.xml EX-101.LAB 19483
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inab-20231206_pre.xml EX-101.PRE 12144
8 EXTRACTED XBRL INSTANCE DOCUMENT d634027d8k_htm.xml XML 3650
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39692 | Film No.: 231472565
SIC: 2836 Biological Products, (No Diagnostic Substances)